Aber Instruments Ltd and Applikon Biotechnology BV reconfigure business partnership

Aber Instruments Ltd and Applikon Biotechnology BV reconfigure business partnership

Aber Instruments and Applikon Biotechnology jointly announce a reconfiguration of their business relationship that will take effect on September 19, 2018.

In response to changing market conditions and the expansion of the Aber Instruments’ US subsidiary, effective September 19, 2018, Applikon is no longer the exclusive distribution partner for the Aber’s products in the North American market.  In a change of approach, Aber and Applikon have established a global OEM agreement.  Aber will supply a dual label reusable viable biomass sensor that can be supplied with Applikon bioprocess control systems.  Aber will sell its reusable Futura and Pico sensor systems via a new network of partners and, in some cases, directly to customers via a newly established US subsidiary Aber Instruments Inc.

Applikon’s CEO, Arthur Oudshoorn commented that “As our relationship with Aber moves from an exclusive distribution agreement for the North American market to a global OEM agreement, we will work closely with Aber to ensure a smooth transition”.  Matthew Lee, Aber’s Managing Director, commented that “this is a new beginning for both companies and we look forward to building a closer relationship with Applikon and to jointly serving our customers with the instrumentation that they have come to rely on to improve bioprocess automation and performance.  At the same time, we look forward to working with new partners in North America to supply world class biomass monitoring and control solutions.

Established in 1988, Aber Instruments Ltd. is a supplier of capacitance based viable biomass monitoring technology to the biotechnology and brewing markets.  The company supplies both reusable and single-use sensors.  In 2017, the company established a subsidiary in the US.

For additional information: visit http://aberinstruments.com/news/filter/type:News or contact John Poppleton, Director of Sales and Marketing via email at  johnp@aberinstruments.com

Applikon Biotechnology is a world leader in developing and supplying advanced bioreactor systems from laboratory-scale, to pilot-, and production scale. We support industrial microbiology and the pharmaceutical industry in their upstream process by implementing scalable platforms from initial screening through development to full-scale production.

For additional information: visit https://www.applikon-biotechnology.com  or contact Erik Kakes, International Sales & Marketing Director via email at press@applikon-biotechnology.com